Immediate Impact
4 from Science/Nature 54 standout
Citing Papers
Programmed death ligand 1 signals in cancer cells
2022 Standout
Atropisomerism in the Pharmaceutically Relevant Realm
2022 Standout
Works of Edit Csada being referenced
Randomized, Placebo-Controlled Phase II Study of Vandetanib Plus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer
2007
A phase II trial of ZD6474 plus docetaxel in patients with previously treated NSCLC: Follow-up results
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Edit Csada | 274 | 246 | 16 | 153 | 8 | 374 | |
| F. Bustin | 351 | 332 | 19 | 121 | 11 | 453 | |
| O. Saunders | 152 | 188 | 15 | 195 | 14 | 357 | |
| Laura Emerson | 283 | 243 | 13 | 87 | 5 | 348 | |
| Dongjun Shin | 306 | 372 | 25 | 84 | 7 | 443 | |
| Yuji Kurusu | 217 | 224 | 75 | 74 | 9 | 423 | |
| Ying A. Wang | 124 | 193 | 40 | 164 | 11 | 408 | |
| Silvia Chiorrini | 112 | 214 | 21 | 115 | 6 | 368 | |
| W D Figg | 219 | 97 | 17 | 145 | 6 | 353 | |
| L.J. Djuric | 279 | 177 | 34 | 43 | 9 | 389 | |
| Erika Rijavec | 148 | 294 | 25 | 105 | 11 | 415 |
All Works
Loading papers...